Trial Profile
A pilot study of memantine for cognitive and behavioral dysfunction in Huntington's disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Jan 2021
Price :
$35
*
At a glance
- Drugs Memantine (Primary)
- Indications Huntington's disease
- Focus Therapeutic Use
- 25 Sep 2020 Status changed from recruiting to completed.